217 related articles for article (PubMed ID: 27872836)
21. Metabolic syndrome, obesity and kidney stones.
Hess B
Arab J Urol; 2012 Sep; 10(3):258-64. PubMed ID: 26558034
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Kidney Stone Formation following Bariatric Surgery.
Prochaska M; Worcester E
Kidney360; 2020 Dec; 1(12):1456-1461. PubMed ID: 34085046
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
Kirsner JB
Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
[TBL] [Abstract][Full Text] [Related]
24. [Urinary stones and bowel diseases: Systematic review].
Pradere B; Peyronnet B; Brochard C; Le Balc'h É; Vigneau C; Siproudhis L; Traxer O; Bensalah K
Prog Urol; 2015 Sep; 25(10):557-64. PubMed ID: 26088584
[TBL] [Abstract][Full Text] [Related]
25. Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis.
Zu'bi F; Sidler M; Harvey E; Lopes RI; Hojjat A; Naoum N; Pokarowski M; Lorenzo AJ; Farhat WA; Papanikolaou F; Dos Santos J
J Pediatr Urol; 2017 Aug; 13(4):357.e1-357.e7. PubMed ID: 28865885
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory bowel disease. Part I: Nature and pathogenesis.
Kirsner JB
Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
[TBL] [Abstract][Full Text] [Related]
27. Stone formation and management after bariatric surgery.
Tarplin S; Ganesan V; Monga M
Nat Rev Urol; 2015 May; 12(5):263-70. PubMed ID: 25850790
[TBL] [Abstract][Full Text] [Related]
28. The role of bariatric surgery in morbidly obese patients with inflammatory bowel disease.
Keidar A; Hazan D; Sadot E; Kashtan H; Wasserberg N
Surg Obes Relat Dis; 2015; 11(1):132-6. PubMed ID: 25547057
[TBL] [Abstract][Full Text] [Related]
29. Nephrolithiasis after bariatric surgery: A review of pathophysiologic mechanisms and procedural risk.
Bhatti UH; Duffy AJ; Roberts KE; Shariff AH
Int J Surg; 2016 Dec; 36(Pt D):618-623. PubMed ID: 27847289
[TBL] [Abstract][Full Text] [Related]
30. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
31. Renal insufficiency in IBD--prevalence and possible pathogenetic aspects.
Primas C; Novacek G; Schweiger K; Mayer A; Eser A; Papay P; Gratzer C; Angelberger S; Dejaco C; Reinisch W; Vogelsang H
J Crohns Colitis; 2013 Dec; 7(12):e630-4. PubMed ID: 23706934
[TBL] [Abstract][Full Text] [Related]
32. Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009.
Varda BK; McNabb-Baltar J; Sood A; Ghani KR; Kibel AS; Letendre J; Menon M; Sammon JD; Schmid M; Sun M; Trinh QD; Bhojani N
Urology; 2015 Apr; 85(4):764-70. PubMed ID: 25669736
[TBL] [Abstract][Full Text] [Related]
33. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of Bariatric Surgery in Patients with Inflammatory Bowel Disease.
Kassir R; Phelip JM; Roblin X; Lointier P; Alamri T; Williet N; Tiffet O
Obes Surg; 2017 Aug; 27(8):2177-2178. PubMed ID: 28555410
[No Abstract] [Full Text] [Related]
35. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
[TBL] [Abstract][Full Text] [Related]
36. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
[TBL] [Abstract][Full Text] [Related]
37. Enteric hyperoxaluria: an important cause of end-stage kidney disease.
Nazzal L; Puri S; Goldfarb DS
Nephrol Dial Transplant; 2016 Mar; 31(3):375-82. PubMed ID: 25701816
[TBL] [Abstract][Full Text] [Related]
38. The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review.
Gambaro G; Croppi E; Bushinsky D; Jaeger P; Cupisti A; Ticinesi A; Mazzaferro S; D'Addessi A; Ferraro PM
J Urol; 2017 Aug; 198(2):268-273. PubMed ID: 28286070
[TBL] [Abstract][Full Text] [Related]
39. The Evolving Role of Retrograde Intrarenal Surgery in the Treatment of Urolithiasis.
Sanguedolce F; Bozzini G; Chew B; Kallidonis P; de la Rosette J
Eur Urol Focus; 2017 Feb; 3(1):46-55. PubMed ID: 28720366
[TBL] [Abstract][Full Text] [Related]
40. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
